Haplotypes of the Monoamine Oxidase Genes and the Risk for Substance Use Disorders

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 125 B, Issue 1, 2004, Pages 120-125

  Vanyukov, Michael M ^a,b   Maher, Brion S ^a   Devlin, Bernie ^a,b   Tarter, Ralph E ^a,b   Kirillova, Galina P ^a   Yu, Ling Mei ^b   Ferrell, Robert E ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Association; Candidate genes; Cladistic analysis; Drug abuse; MAO; Measured haplotype analysis

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING);

ADULT; ARTICLE; CLADISTICS; CONTROLLED STUDY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE;

EID: 0942301428     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20105     Document Type: Article

References (38)

1. Balciuniene J, Emilsson L, Oreland L, Pettersson U, Jazin E. 2002. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum Genet 110:1-7.
2. Black GC, Chen ZY, Craig IW, Powell JF. 1991. Dinucleotide repeat polymorphism at the MAOA locus. Nucleic Acids Res 19:689.
3. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. 1993a. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262:578-580.
4. Brunner HG, Nelen MR, van Zandvoort NG, Abeling NGGM, van Gennip AH, Wolters EC, Kuiper MA, Ropers HH, van Oost BA. 1993b. X-linked borderline mental retardation with prominent behavioral disturbance: Phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet 52:1032-1039.
5. Devlin B, Maher BS, Yu L-M, Ferrell RE, Vanyukov MM. (Under review). Evolution of haplotypes at the monoamine oxidase locus inferred from European-American and African-American samples.
6. Devlin B, Roeder K, Bacanu SA. 2001a. Unbiased methods for population-based association studies. Genet Epidemiol 21:273-284.
7. Devlin B, Roeder K, Wasserman L. 2001b. Genomic control, a new approach to genetic-based association studies. Theor Popul Biol 60:155-166.
8. Fowler CJ, Wiberg A, Oreland L, Marcusson J, Winblad B. 1980. The effect of age on the activity and molecular properties of human brain monoamine oxidase. J Neural Transm 49:1-20.
9. Gade R, Muhleman D, Blake H, MacMurray J, Johnson P, Verde R, Saucier G, Comings DE. 1998. Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse. Mol Psychiatry 3:50-60.
10. Hinds HL, Hendriks RW, Craig IW, Chen ZY. 1992. Characterization of a highly polymorphic region near the first exon of the human MAOA gene containing a GT dinucleotide and a novel VNTR motif. Genomics 13:896-897.
11. Hotamisligil GS, Breakefield XO. 1991. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 49:383-392.
12. Hsu YP, Loh EW, Chen WJ, Chen CC, Yu JM, Cheng AT. 1996. Association of monoamine oxidase A alleles with alcoholism among male Chinese in Taiwan. Am J Psychiatry 153:1209-1211.
13. Kendler KS, Jacobson KC, Prescott CA, Neale MC. 2003. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 160:687-695.
14. Kosten TA, Rounsaville BJ. 1992. Sensitivity of psychiatric diagnosis based on the best estimate procedure. Am J Psychiatry 149:1225-1227.
15. Lu RB, Lee JF, Ko HC, Lin WW, Chen K, Shih JC. 2002. No association of the MAOA gene with alcoholism among Han Chinese males in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry 26:457-461.
16. McGue M, Pickens RW, Svikis DS. 1992. Sex and age effects on the inheritance of alcohol problems: A twin study. J Abnorm Psychol 101: 3-17.
17. Nguyen H, Roeder K, Devlin B, Maher BS, Yu L-M, Ferrell RE, Vanyukov MM. (Under review). A method for inferring evolutionary relationships among haplotypes, exemplified by haplotypes at the monoamine oxidase locus.
18. O'Connell JR, Weeks DE. 1998. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63:259-266.
19. Parsian A, Suarez BK, Tabakoff B, Hoffman P, Ovchinnikova L, Fisher L, Cloninger CR. 1995. Monoamine oxidases and alcoholism. I. Studies in unrelated alcoholics and normal controls. Am J Med Genet 60:409-416.
20. Sabol SZ, Hu S, Hamer D. 1998. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103:273-279.
21. Saito T, Lachman HM, Diaz L, Hallikainen T, Kauhanen J, Salonen JT, Ryynanen OP, Karvonen MK, Syvalahti E, Pohjalainen T, Hietala J, Tiihonen J. 2002. Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics. Psychiatry Res 109:113-119.
22. Samochowiec J, Lesch KP, Rottmann M, Smolka M, Syagailo YV, Okladnova O, Rommelspacher H, Winterer G, Schmidt LG, Sander T. 1999. Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism. Psychiatry Res 86:67-72.
23. Sham PC, Curtis D. 1995. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105.
24. Shih JC, Grimsby J, Chen K, Zhu QS. 1993. Structure and promoter organization of the human monoamine oxidase A and B genes. J Psychiatry Neurosci 18:25-32.
25. Spitzer R, Williams J, Gibbons B. 1987. Instruction manual for the structured clinical interview for the DSM-III-R. New York: Biometric Research Department, New York State Psychiatric Institute.
26. Tarter RE. 1990. Evaluation and treatment of adolescent substance abuse: A decision tree method. Am J Drug Alcohol Abuse 16:1-46.
27. Tarter RE, Kirisci L. 1997. The drug use screening inventory for adults: Psychometric structure and discriminative sensitivity. Am J Drug Alcohol Abuse 23:207-219.
28. Tarter RE, Kirisci L. 2001. Validity of the drug use screening inventory for predicting DSM-III-R substance use disorder. J Child Adolesc Subst Abuse 10:45-53.
29. Tarter RE, Vanyukov M. 1994. Alcoholism: A developmental disorder. J Cons Clin Psychol 62:1096-1107.
30. Tarter RE, Vanyukov MM. 2001. Introduction: Theoretical and operational framework for research into the etiology of substance use disorders. J Child Adoles Subst Abuse 10:1-12.
31. Templeton AR. 1995. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping or DNA sequencing. V. Analysis of case/control sampling designs: Alzheimer's disease and the apoprotein E locus. Genetics 140:403-409.
32. Templeton AR, Sing SF. 1993. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. IV. Nested analysis with cladogram uncertainty and recombination. Genetics 134:659-669.
33. Templeton AR, Boerwinkle E, Sing CF. 1987. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and an analysis of alcohol dehydrogenase activity in Drosophila. Genetics 117:343-351.
34. Templeton AR, Crandall KA, Sing CF. 1992. A cladistic analysis of phenotype associations with haplotypes inferred from restriction nuclease mapping and DNA sequence data. III. Cladogram estimation. Genetics 120:1145-1154.
35. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, True W, Lin N, Toomey R, Eaves L. 1998. Co-occurrence of abuse of different drugs in men: The role of drug- specific and shared vulnerabilities. Arch Gen Psychiat 55:967-972.
36. Vanyukov MM, Tarter RE. 2000. Genetic studies of substance abuse. Drug Alcohol Depend 59:101-123.
37. Vanyukov MM, Moss HB, Yu L-M, Tarter RE, Deka R. 1995a. Preliminary evidence for an association of a dinucleotide repeat polymorphism at the MAOA gene with early onset alcoholism/substance abuse. Am J Med Genet (Neuropsychiat Genet) 60:122-126.
38. Vanyukov MM, Moss HB, Yu L-M, Deka R. 1995b. A dinucleotide repeat polymorphism at the gene for monoamine oxidase A and measures of aggressiveness. Psychiatry Res 59:35-41.